Madrigal Pharmaceuticals (MDGL) Other Gross PP&E Adjustments (2019 - 2025)
Historic Other Gross PP&E Adjustments for Madrigal Pharmaceuticals (MDGL) over the last 14 years, with Q3 2025 value amounting to -$5.4 million.
- Madrigal Pharmaceuticals' Other Gross PP&E Adjustments fell 11445.06% to -$5.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.4 million, marking a year-over-year decrease of 11445.06%. This contributed to the annual value of -$18.7 million for FY2024, which is 4748.24% up from last year.
- Per Madrigal Pharmaceuticals' latest filing, its Other Gross PP&E Adjustments stood at -$5.4 million for Q3 2025, which was down 11445.06% from -$5.9 million recorded in Q2 2025.
- Over the past 5 years, Madrigal Pharmaceuticals' Other Gross PP&E Adjustments peaked at -$411000.0 during Q2 2023, and registered a low of -$35.7 million during Q4 2023.
- For the 5-year period, Madrigal Pharmaceuticals' Other Gross PP&E Adjustments averaged around -$7.1 million, with its median value being -$1.6 million (2024).
- As far as peak fluctuations go, Madrigal Pharmaceuticals' Other Gross PP&E Adjustments skyrocketed by 6111.64% in 2023, and later crashed by 30260.99% in 2025.
- Over the past 5 years, Madrigal Pharmaceuticals' Other Gross PP&E Adjustments (Quarter) stood at -$25.1 million in 2021, then dropped by 10.73% to -$27.8 million in 2022, then fell by 28.25% to -$35.7 million in 2023, then skyrocketed by 47.48% to -$18.7 million in 2024, then soared by 71.26% to -$5.4 million in 2025.
- Its last three reported values are -$5.4 million in Q3 2025, -$5.9 million for Q2 2025, and -$2.1 million during Q1 2025.